Trial · NCT02426086
Results by group74
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 74
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Spleen Response | Imetelstat 4.7 mg/kg | 0 | 95% Confidence Interval 0 to 7.4 | percentage of participants | |
| Percentage of Participants With Spleen Response | Imetelstat 9.4 mg/kg | 10.2 | 95% Confidence Interval 3.8 to 20.8 | percentage of participants | |
| Percentage of Participants With Symptom Response | Imetelstat 4.7 mg/kg | 6.3 | 95% Confidence Interval 1.3 to 17.2 | percentage of participants | |
| Percentage of Participants With Symptom Response | Imetelstat 9.4 mg/kg | 32.2 | 95% Confidence Interval 20.6 to 45.6 | percentage of participants | |
| Percentage of Participants With Overall Response as Per Modified 2013 International Working Group - Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) Criteria | Imetelstat 4.7 mg/kg | 0 | 95% Confidence Interval NA to NA | percentage of participants | |
| Percentage of Participants With Overall Response as Per Modified 2013 International Working Group - Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) Criteria | Imetelstat 9.4 mg/kg | 1.7 | 95% Confidence Interval 0.0 to 9.1 | percentage of participants | |
| Percentage of Participants With Clinical Improvement (CI) Per Modified 2013 IWG-MRT Criteria | Imetelstat 4.7 mg/kg | 16.7 | percentage of participants | ||
| Percentage of Participants With Clinical Improvement (CI) Per Modified 2013 IWG-MRT Criteria | Imetelstat 9.4 mg/kg | 25.4 | percentage of participants | ||
| Percentage of Participants With Clinical Response Per Modified 2013 IWG-MRT | Imetelstat 4.7 mg/kg | 16.7 | 95% Confidence Interval 7.5 to 30.2 | percentage of participants | |
| Percentage of Participants With Clinical Response Per Modified 2013 IWG-MRT | Imetelstat 9.4 mg/kg | 27.1 | 95% Confidence Interval 16.4 to 40.3 | percentage of participants | |
| Percentage of Participants With Spleen Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 4.7 mg/kg | Spleen response with CI | 0 | percentage of participants | |
| Percentage of Participants With Spleen Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 9.4 mg/kg | Spleen response with CI | 3.4 | percentage of participants | |
| Percentage of Participants With Spleen Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 4.7 mg/kg | Spleen response without CI | 2.1 | percentage of participants | |
| Percentage of Participants With Spleen Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 9.4 mg/kg | Spleen response without CI | 0 | percentage of participants | |
| Percentage of Participants With Symptoms Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 4.7 mg/kg | Symptom response with CI | 14.6 | percentage of participants | |
| Percentage of Participants With Symptoms Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 9.4 mg/kg | Symptom response with CI | 22.0 | percentage of participants | |
| Percentage of Participants With Symptoms Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 4.7 mg/kg | Symptom response without CI | 4.2 | percentage of participants | |
| Percentage of Participants With Symptoms Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 9.4 mg/kg | Symptom response without CI | 8.5 | percentage of participants | |
| Percentage of Participants With Anemia Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 4.7 mg/kg | Anemia response with CI | 4.2 | percentage of participants | |
| Percentage of Participants With Anemia Response Per Modified 2013 IWG-MRT Criteria | Imetelstat 9.4 mg/kg | Anemia response with CI | 6.8 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02426086/results